How they do it at Shire Pharmaceuticals

Shire Pharmaceuticals is rising high - from nowhere to the FTSE 100 within a couple of years of going public. Investors and analysts attribute at least part of its continuing rise to the assiduous IR of Cla Rosenfeld, whose cosmopolitan background equips her well for the far-flung stockholder base of the company.French, educated in Switzerland, and a management trainee in New York, she launched into IR by joining Technimetrics four years ago, and stayed when Technimetrics was acquired by Thomson